Results 181 to 190 of about 9,117 (217)
Some of the next articles are maybe not open access.
Management of Graves' ophthalmopathy
Nature Clinical Practice Endocrinology & Metabolism, 2007Management of Graves' ophthalmopathy is preferably done in a multidisciplinary setting. Smoking is associated with worse disease outcome. (131)I therapy for hyperthyroidism can also worsen ophthalmopathy, especially if administered during active disease or to patients who smoke or have severe hyperthyroidism, or those with high levels of TSH-receptor ...
openaire +2 more sources
Introduction to Graves’ ophthalmopathy
2000Although the pathogenesis of Graves’ ophthalmopathy is incompletely understood, we have a rather good insight as to how the pathologic changes in the orbit cause (in a mechanical way) the clinical characteristics. To better understand this it is important to be acquainted with the anatomy of the orbit.
Prummel, M.F. +4 more
openaire +2 more sources
Immunosuppressive treatment of Graves' ophthalmopathy
Trends in Endocrinology & Metabolism, 1990Steroids or orbital irradiation are effective in approximately 60% of patients with severe Graves' ophthalmopathy; the improvement of proptosis and extraocular muscle dysfunction, however, is limited. Better results are obtained by the combination of orbital irradiation and systemic steroids.
openaire +5 more sources
Tocilizumab in Graves ophthalmopathy
Medicina Clínica (English Edition), 2020Gemma, Garreta Fontelles +2 more
openaire +2 more sources
Euthyroid Graves’ ophthalmopathy
QJM: An International Journal of Medicine, 2023A Schattner +3 more
openaire +2 more sources
Treatment of Graves' ophthalmopathy
Medicina Clínica (English Edition), 2022openaire +2 more sources